ETON - Eton Pharmaceuticals GAAP EPS of $0.04 beats by $0.03 revenue of $8.5M misses by $0.62M
2023-03-16 16:10:58 ET
- Eton Pharmaceuticals press release ( NASDAQ: ETON ): Q4 GAAP EPS of $0.04 beats by $0.03 .
- Revenue of $8.5M (+39.6% Y/Y) misses by $0.62M .
-
Gross Profit: Gross profit for the fourth quarter of 2022 was $6.4 million compared with $5.7 million in the prior year period.
-
Research and Development (R&D) Expenses: R&D expenses for the fourth quarter of 2022 were $0.9 million compared to $0.7 million in the prior year period.
-
Cash Position: As of December 31, 2022, the Company had cash and cash equivalents of $16.3 million.
For further details see:
Eton Pharmaceuticals GAAP EPS of $0.04 beats by $0.03, revenue of $8.5M misses by $0.62M